JAAD Case Reports (Sep 2021)

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab

  • Thomas Buttgereit, MD,
  • Eva Maria Grekowitz, MD,
  • Martin Metz, MD

DOI
https://doi.org/10.1016/j.jdcr.2021.06.028
Journal volume & issue
Vol. 15
pp. 36 – 38

Abstract

Read online

No abstracts available.

Keywords